Pharmacokinetic Research Progress of Anti-tumor Drugs Targeting for Pulmonary Administration

被引:3
|
作者
Zhao, Mengfan [1 ]
Jing, Ziwei [1 ]
Zhou, Lin [1 ]
Zhao, Hongyu [2 ]
Du, Qiuzheng [1 ]
Sun, Zhi [1 ]
机构
[1] Zhengzhou Univ, Dept Pharm, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China
基金
中国国家自然科学基金;
关键词
Lung cancer; inhalation preparation; drug carrier; pharmacokinetics; anti-tumor drugs; pulmonary administration; CELL LUNG-CANCER; MICELLIZING SOLID DISPERSION; DELIVERY-SYSTEMS; DRY POWDER; INHALATION TREATMENT; CYCLOSPORINE-A; PHASE-II; NANOPARTICLES; LIPOSOMES; FORMULATION;
D O I
10.2174/1389200221999201111193910
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Cancer is a major problem that threatens human survival and has a high mortality rate. The traditional chemotherapy methods are mainly intravenous injection and oral administration, but have obvious toxic and side effects. Anti-tumor drugs for pulmonary administration can enhance drug targeting, increase local drug concentration, and reduce the damage to systemic organs, especially for the treatment of lung cancer. Methods: The articles on the pharmacokinetics of anti-tumor drugs targeting pulmonary administration were retrieved from the Pub Med database. This article mainly took lung cancer as an example and summarized the pharmacokinetic characteristics of anti-tumor drugs targeting for pulmonary administration contained in nanoparticles, dendrimers, liposomes and micelles. Results: The review shows that the pharmacokinetics process of pulmonary administration is associated with a drug carrier by increasing the deposition and release of drugs in the lung, and retarding the lung clearance rate. Among them, the surface of dendrimers could be readily modified, and polymer micelles have favorable loading efficiency. In the case of inhalation administration, liposomes exhibit more excellent lung retention properties compared to other non-lipid carriers. Therefore, the appropriate drug carrier is instrumental to increase the curative effect of anti-tumor drugs and reduce the toxic effect on surrounding healthy tissues or organs. Conclusion: In the process of pulmonary administration, the carrier-embedded antitumor drugs have the characteristics of targeted and sustained release compared with non-packaging drugs, which provides a theoretical basis for the clinical rational formulation of chemotherapy regimens. llowever, there is currently a lack of comparative research between drug packaging materials, and more importantly, the development of safe and effective anti-tumor drugs targeting for pulmonary administration requires more data.
引用
收藏
页码:1117 / 1126
页数:10
相关论文
共 50 条
  • [41] COOPERATIVITY IN THE BINDING OF ANTI-TUMOR DRUGS TO DNA
    WINKLE, SA
    KRUGH, TR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1980, 180 (AUG): : 205 - BIOL
  • [42] Development of natural anti-tumor drugs by microorganisms
    Chang, Chia-Che
    Chen, Wei-Chuan
    Ho, Tsing-Fen
    Wu, Ho-Shing
    Wei, Yu-Hong
    JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2011, 111 (05) : 501 - 511
  • [43] Intracellular sequestration of anti-tumor drugs by metallothionein
    He, T
    Wei, D
    Fabris, D
    Fenselau, C
    CELLULAR AND MOLECULAR BIOLOGY, 2000, 46 (02) : 383 - 392
  • [44] INVITRO NEUROTOXIC ASSESSMENT OF ANTI-TUMOR DRUGS
    WHATLEY, SA
    HILL, BT
    CANCER LETTERS, 1983, 20 (01) : 75 - 82
  • [45] THE INTERACTION OF IMMUNOSTIMULATORY GLYCOPEPTIDES WITH ANTI-TUMOR DRUGS
    MASEK, K
    JIRICKA, Z
    JANKU, I
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1980, 2 (03): : 223 - 223
  • [46] TRANSPORT OF ANTI-TUMOR DRUGS BY LEUKOCYTES IN VITRO
    KESSEL, D
    FEDERATION PROCEEDINGS, 1966, 25 (2P1) : 561 - &
  • [47] NEW ANTI-TUMOR DRUGS FROM PLANTS
    ARCAMONE, F
    CASSINELLI, G
    CASAZZA, AM
    JOURNAL OF ETHNOPHARMACOLOGY, 1980, 2 (02) : 149 - 160
  • [48] THE STABILITY OF THE LETHAL EFFICACY OF ANTI-TUMOR DRUGS
    YANG, LY
    DREWINKO, B
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 315 - 315
  • [49] CD79b targeting ADC with superior pharmacokinetic profile and anti-tumor activity.
    Spycher, Philipp Rene
    Probst, Philipp
    Bertrand, Romain
    Stark, Ramona
    Santimaria, Roger
    Grabulovski, Dragan
    Attinger-Toller, Isabella
    CANCER RESEARCH, 2021, 81 (13)
  • [50] Targeting tumor cells with antibodies enhances anti-tumor immunity
    Zhichen Sun
    Yang-Xin Fu
    Hua Peng
    BiophysicsReports, 2018, 4 (05) : 243 - 253